TRIER PHARM ApS: Financial statements 2012
CVR: 31611083
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 176,939 and a net result of DKK 42,979. The profit margin was 24.3%. Equity in the 2012 report amounted to DKK 777,614. The solvency ratio was 95.4%.
- Revenue
- DKK 176,939
- Gross Profit
- DKK 52,756
- Profit/Loss
- DKK 42,979
- Equity
- DKK 777,614
- Total Assets
- DKK 815,266
Official annual report
Keep an eye on TRIER PHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.